Anticancer Potential of Diiron Vinyliminium Complexes

Area of Science:

• Organometallic Chemistry
• Medicinal Chemistry
• Cancer Research

Background:

• Ferrocene derivatives are explored for anticancer properties.
• The potential of diiron complexes in cancer therapy remains largely uninvestigated.

Purpose of the Study:

• To synthesize and evaluate a series of diiron cyclopentadienyl complexes with bridging vinyliminium ligands for antiproliferative activity.
• To assess the selectivity and mechanism of action of these novel diiron complexes against cancer cell lines.

Main Methods:

• Multigram-scale synthesis of diiron vinyliminium complexes.
• Antiproliferative assays using cisplatin-sensitive and resistant human ovarian carcinoma cell lines (A2780, A2780cisR).
• Cytotoxicity evaluation against non-tumoral human embryonic kidney (HEK-293) cells.

Main Results:

• Compounds exhibited IC50 values in the low-to-mid micromolar range against ovarian cancer cells.
• Selected complexes demonstrated notable selectivity towards cancer cells over HEK-293 cells.
• Anticancer activity involved reactive oxygen species (ROS) generation and potential fragmentation into monoiron species.

Conclusions:

• Diiron vinyliminium complexes represent a promising class of iron-based anticancer agents.
• These complexes possess favorable properties including structural variability, amphiphilicity, and stability in aqueous media.
• Further investigation into these compounds could lead to novel therapeutic strategies for ovarian cancer.